Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons

In the European Union, all medicines must include appropriate labelling and the respective patient information leaflet (PIL), which is the most reachable source of medicine’s information for patients. This document includes a set of information understandable by their potential users and complementa...

Full description

Bibliographic Details
Main Authors: Margarida Espírito-Santo, Tânia Nascimento, Ezequiel Pinto, M. Dulce Estêvão
Format: Article
Language:English
Published: Karger Publishers 2023-02-01
Series:Portuguese Journal of Public Health
Subjects:
Online Access:https://www.karger.com/Article/FullText/528664
_version_ 1811157643925913600
author Margarida Espírito-Santo
Tânia Nascimento
Ezequiel Pinto
M. Dulce Estêvão
author_facet Margarida Espírito-Santo
Tânia Nascimento
Ezequiel Pinto
M. Dulce Estêvão
author_sort Margarida Espírito-Santo
collection DOAJ
description In the European Union, all medicines must include appropriate labelling and the respective patient information leaflet (PIL), which is the most reachable source of medicine’s information for patients. This document includes a set of information understandable by their potential users and complementary to the information provided by health professionals. The ageing of the Portuguese population raises the need for the appropriateness of medicine’s information for older consumers, taking into account their specific needs arising from physiological changes impacting drug action. This project aimed to analyse the content of medicines’ PILs, specifically directed at older persons. A sample of medicines was selected considering the 100 active substances more consumed in Portugal by patients with chronic pathologies such as diabetes mellitus, hypertension, and dyslipidaemia. The analysis included readability, legibility, and content (directly and indirectly related to the use of medicines by older persons). A total of 69 PILs were analysed, and it was observed that the information provided about the drugs was included in most of these PILs (95.7%; n = 66) but without any specific information for patients belonging to different age groups. Signalling-specific warnings for older persons were only available in less than half of the PILs (46.4%; n = 32). The presence of relevant information on the appropriate use of the drug such as the recommended dose was only specified for older persons in 28% (n = 19) of the analysed PILs. The information available in PILs which can be considered as specifically directed to older persons is relatively scarce, even in areas as critical as the instructions for use. Hopefully, these results will contribute to increasing awareness regarding the need to adapt PILs’ content to specific consumers and to test them to guarantee that they are adequate for all potential consumers.
first_indexed 2024-04-10T05:10:44Z
format Article
id doaj.art-aa695118e3de4104b373918253acf609
institution Directory Open Access Journal
issn 2504-3137
2504-3145
language English
last_indexed 2024-04-10T05:10:44Z
publishDate 2023-02-01
publisher Karger Publishers
record_format Article
series Portuguese Journal of Public Health
spelling doaj.art-aa695118e3de4104b373918253acf6092023-03-09T08:59:36ZengKarger PublishersPortuguese Journal of Public Health2504-31372504-31452023-02-011710.1159/000528664528664Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older PersonsMargarida Espírito-Santo0https://orcid.org/0000-0002-2200-0015Tânia Nascimento1https://orcid.org/0000-0003-2429-7374Ezequiel Pinto2https://orcid.org/0000-0001-9322-2937M. Dulce Estêvão3https://orcid.org/0000-0002-7151-8363Escola Superior de Saúde, Universidade do Algarve, Faro, PortugalEscola Superior de Saúde, Universidade do Algarve, Faro, PortugalEscola Superior de Saúde, Universidade do Algarve, Faro, PortugalEscola Superior de Saúde, Universidade do Algarve, Faro, PortugalIn the European Union, all medicines must include appropriate labelling and the respective patient information leaflet (PIL), which is the most reachable source of medicine’s information for patients. This document includes a set of information understandable by their potential users and complementary to the information provided by health professionals. The ageing of the Portuguese population raises the need for the appropriateness of medicine’s information for older consumers, taking into account their specific needs arising from physiological changes impacting drug action. This project aimed to analyse the content of medicines’ PILs, specifically directed at older persons. A sample of medicines was selected considering the 100 active substances more consumed in Portugal by patients with chronic pathologies such as diabetes mellitus, hypertension, and dyslipidaemia. The analysis included readability, legibility, and content (directly and indirectly related to the use of medicines by older persons). A total of 69 PILs were analysed, and it was observed that the information provided about the drugs was included in most of these PILs (95.7%; n = 66) but without any specific information for patients belonging to different age groups. Signalling-specific warnings for older persons were only available in less than half of the PILs (46.4%; n = 32). The presence of relevant information on the appropriate use of the drug such as the recommended dose was only specified for older persons in 28% (n = 19) of the analysed PILs. The information available in PILs which can be considered as specifically directed to older persons is relatively scarce, even in areas as critical as the instructions for use. Hopefully, these results will contribute to increasing awareness regarding the need to adapt PILs’ content to specific consumers and to test them to guarantee that they are adequate for all potential consumers.https://www.karger.com/Article/FullText/528664consumer health informationhealth literacymedicinesolder personspatient information leaflet
spellingShingle Margarida Espírito-Santo
Tânia Nascimento
Ezequiel Pinto
M. Dulce Estêvão
Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
Portuguese Journal of Public Health
consumer health information
health literacy
medicines
older persons
patient information leaflet
title Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
title_full Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
title_fullStr Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
title_full_unstemmed Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
title_short Patient Information Leaflets of Drugs Used in Cardiometabolic Disorders: Suitability for Use by Older Persons
title_sort patient information leaflets of drugs used in cardiometabolic disorders suitability for use by older persons
topic consumer health information
health literacy
medicines
older persons
patient information leaflet
url https://www.karger.com/Article/FullText/528664
work_keys_str_mv AT margaridaespiritosanto patientinformationleafletsofdrugsusedincardiometabolicdisorderssuitabilityforusebyolderpersons
AT tanianascimento patientinformationleafletsofdrugsusedincardiometabolicdisorderssuitabilityforusebyolderpersons
AT ezequielpinto patientinformationleafletsofdrugsusedincardiometabolicdisorderssuitabilityforusebyolderpersons
AT mdulceestevao patientinformationleafletsofdrugsusedincardiometabolicdisorderssuitabilityforusebyolderpersons